EUCTR2014-003785-24-HU进行中（未招募）1 期
Treatment of pancreatic adenocarcinoma with the combinationof carboplatin and velparib
zsoki Utcai Kórház0 个研究点开始时间: 2014年9月12日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •inoperable pancretaic adenocarcinoma with ATM-P604S mutation
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •operable pancreas tumor at the screening CT
研究者
相似试验
进行中（未招募）
不适用
ltrasound-assisted treatment of inoperable pancreatic cancer. ”Behandling av inoperabel kreft i bukspyttkjertelen ved å kombinere kontrast ultralyd og gemcitabin under sonoporering”Patients with inoperable pancreatic cancer.Histologically verified, locally advanced (nonresectable Stage II/III) or metastatic (Stage IV) adenocarcinoma of the pancreas. The patients must be ambulatory with an ECOG performance status 0-2.EUCTR2010-024289-24-NOHelse Bergen HF, Haukeland Unversity Hospital10
招募中
1 期
Chemotherapy for advanced pancreatic cancer with combined usage of gemcitabine and GSK3beta-inhibiting medicinesadvanced pancreatic cancerJPRN-UMIN0000050951)Multidisciplinary Cancer Center,Kanazawa Medical University Hospital 2)Department of Surgical Oncology, Kanazawa Medical University Hospital6
已完成
不适用
Strategies for Coping with Pancreatic CancerC25Malignant neoplasm of pancreasDRKS00020251Hochschule Osnabrück, University of Applied Sciences26
终止
2 期
Treatment of Pancreatic Insufficiency Using Creon in Patients with Pancreatic CancerPancreatic carcinomaCancer - PancreaticCancer - Biliary tree (gall bladder and bile duct)ACTRN12612000299808Calvary Mater Newcastle60
进行中（未招募）
1 期
ordic Pancreatic Cancer TrialResectable pancreatic cancerMedDRA version: 21.0Level: LLTClassification code 10033604Term: Pancreatic cancerSystem Organ Class: 100000004864EUCTR2015-001635-21-DKorwegian Gastointestinal Cancer Group140